UPDATE : Monday, October 15, 2018
ViroMed secures DNA production plant in US by Marian Chu 2018-07-18 15:02
Dong-A ST’s Jublia dominates athlete’s foot drugs by So Jae-hyeon 2018-07-18 11:50
Novo Nordisk Korea gets nod for diabetes drug Fiasp by Marian Chu 2018-07-18 11:50
‘Koreans increasingly seeking out hair loss treatment’ by Marian Chu 2018-07-17 16:08
YD Life Science to proceed with P2 trial for diabetic retinopathy treatment by Lee Han-soo 2018-07-17 14:52
30% of psoriasis patients take more than 5 years to find correct therapy by Marian Chu 2018-07-17 14:52
Pharmbio launched CINV treatment by Lee Han-soo 2018-07-17 14:02
Korean eye drops selling well overseas by So Jae-hyeon 2018-07-17 11:36
Multinational pharma focus on P3 trials; locals have more P1 trials by Marian Chu 2018-07-17 11:27
Access Bio signs $1.12-mil. contract for malaria diagnostic test by Marian Chu 2018-07-16 16:23
FDA nods Qurient’s multidrug-resistant TB treatment for P2 clinical trials by Lee Han-soo 2018-07-16 15:10
Korean take more drugs than OECD average by Lee Han-soo 2018-07-16 12:37
Japanese drugmakers in Korea showed robust performances last year by Lee Han-soo 2018-07-13 16:32
Samsung BioLogics violated accounting standards: SFC by Lee Han-soo 2018-07-12 18:36
Edarbi, Saxenda prescribed in major hospitals by So Jae-hyeon 2018-07-11 15:42
‘Invossa-K will get US approval in 3 years, mark billion dollar sales’ by Lee Han-soo 2018-07-10 17:01
Orders for original drugs spike amid ban of Chinese valsartan by Park Gi-taek 2018-07-10 16:03
Shire launches new Hemophilia A treatment in Korea by Lee Han-soo 2018-07-10 13:51
Ban of antihypertensive drug puts Korean drugmakers in panic by Lee Hye-seon/Nam Doo-hyun 2018-07-09 16:24
Local drug makers strive to conquer neurological diseases by So Jae-hyeon 2018-07-09 12:09
Back to Top